✦ LIBER ✦

Evaluation of the risk of therapy-related MDS/AML after autologous stem cell transplantation

✍ Scribed by D.Gary Gilliland; John G Gribben

Book ID: 117816203
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 277 KB
Volume: 8
Category: Article
ISSN: 1083-8791
DOI: 10.1053/bbmt.2002.v8.pm11846355

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Renaissance of autologous stem cell tran

Renaissance of autologous stem cell transplantation for AML?

✍ Felicetto Ferrara 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 109 KB

Predictors of Therapy-Related Myelodyspl

Predictors of Therapy-Related Myelodysplasia and Acute Myeloid Leukemia (t-MDS/AML) After Autologous Hematopoietic Cell Transplantation (AHCT) for Hematologic Malignancies

✍ C.-L. Sun; J.B. Teh; L. Tomassian; J. Gyorffy; S. Wang; L. Popplewell; A. Krishn 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 73 KB

The relapse risk of AML patients undergo

The relapse risk of AML patients undergoing autologous transplantation correlates with the stem cell mobilizing potential

✍ Isabelle von Grünigen; Joëlle Raschle; Ilka Rüsges-Wolter; Behrouz Mansouri Tale 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 368 KB

Prediction of therapy-related acute myel

Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma

✍ Legare, Robert D.; Gribben, John G.; Maragh, Marlon; Hermanowski-Vosatka, Anne; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 2 views

Therapy-related acute myelogenous leukemia and myelodysplastic syndrome (t-AML/ MDS) are being reported with increasing frequency as a complication of ABMT for Hodgkin's disease and non-Hodgkin's lymphoma. At present there is no method available to predict who is at risk or is destined to develop th

Treatment of AML and MDS relapsing after

Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation

✍ Oran, B; Giralt, S; Couriel, D; Hosing, C; Shpall, E J; de Meis, E; Khouri, I F; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

Azacitidine and donor lymphocyte infusio

Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

✍ Schroeder, T; Czibere, A; Platzbecker, U; Bug, G; Uharek, L; Luft, T; Giagounidi 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 435 KB